analysis. Cumulative observed survival rate (OS) and relative survival rate (RS) were calculated using Hakulinen's method performed by the SURV 3.01 software developed at the Finnish Cancer Registry. Results The 1-, 3-, and 5-year OS rates were 23.73%, 11.89%, 10.01%, and the RS rates were 24.86%, 13.69%, 12.73%, respectively. The 1-, 3-, and 5-year RS of males vs females were 23 www.lungca.org
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